Abstract:Abstract Background The SARS-Coronavirus-2 (SARS-CoV-2) invades the respiratory system, causing acute and sometimes severe pulmonary symptoms, but turned out to also act multisystematically with substantial impact on the brain. A growing number of studies suggests a diverse spectrum of neurological manifestations. To investigate the spectrum of symptoms, we here describe the neurological manifestations and complications of patients with proven SARS-CoV-2 infection who have been hospitalized at the RWTH University Hospital Aachen, Germany. Methods Between March and September 2020, we evaluated common symptoms, clinical characteristics, laboratory (including cerebrospinal fluid (CSF) analysis), radiological, and electroencephalography (EEG) data from 53 patients admitted with a positive SARS-CoV-2 polymerase chain reaction (PCR). We used the Montreal Cognitive Assessment Test (MoCA) to screen for cognitive impairment, when feasible. We compared critically ill and non-critically ill patients categorized according to the presence of Acute Respiratory Distress Syndrome (ARDS). Results Major clinical neurological features of hospitalized COVID-19 patients were coordination deficits (74%), cognitive impairment (61.5%), paresis (47%), abnormal reflex status (45%), sensory abnormalities (45%), general muscle weakness and pain (32%), hyposmia (26%), and headache (21%). Patients with ARDS were more severely affected than non-ADRS patients. 29.6% of patients with ARDS presented with subarachnoid bleedings, and 11.1% showed ischemic stroke associated with SARS-CoV-2 infection. Cognitive deficits mainly affected executive functions, attention, language, and delayed memory recall. We obtained cerebrospinal fluid (CSF) by lumbar puncture in nine of the 53 patients, none of which had a positive SARS-CoV-2 PCR. Conclusions In line with previous findings, our results provide evidence for a range of SARS-CoV-2-associated neurological manifestations. 26% of patients reported hyposmia, emphasizing the neuro-invasive potential of SARS-CoV-2, which can enter the olfactory bulb. It can therefore be speculated that neurological manifestations may be caused by direct invasion of the virus in the CNS; however, PCR did not reveal positive intrathecal SARS-CoV-2. Therefore, we hypothesize it is more likely that the para-infectious severe pro-inflammatory impact of COVID-19 is responsible for the neurological deficits including cognitive impairment. Future studies with comprehensive longitudinal assessment of neurological deficits are required to determine potential long-term complications of COVID-19.

Characteristics of Neuropsychiatric Impairment Symptoms in Patients with Severe Acute Respiratory Syndrome

Neurological manifestations in severe acute respiratory syndrome

Neurological and Psychiatric Presentations Associated with COVID-19

[Psychological and Physical Presentations of Severe Acute Respiratory Syndrome].

Clinical Analysis of 120 Cases of Patients with Severe Acute Respiratory Syndrome

[Retrospective Analysis on Clinical Features of 35 Patients with Severe Acute Respiratory Syndrome].

Analysis of Respiratory Symptoms in 409 Patients with Severe Acute Respiratory Syndrome

Pooled-analysis on Clinical Features of Human Infection with Severe Acute Respiratory Syndrome

[The Clinical Characteristics and Staging of Severe Acute Respiratory Syndrome].

Central Nervous System Complications in SARS-CoV-2-infected Patients.

Clinical Features of Probable Severe Acute Respiratory Syndrome in Beijing.

Analysis of Severe Acute Respiratory Syndrome in Beijing

Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients

Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions

Clinical and Imaging Findings in Patients with Severe Acute Respiratory Syndrome.

Cohort Study on Relationship between Psychological Health Status and Clinical Features in Patients with Severe Acute Respiratory Syndrome

Clinical Analysis of 45 Patients with Severe Acute Respiratory Syndrome

Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study

Biological correlates of the neuropsychiatric symptoms in SARS-CoV-2 infection: an updated review

Clinical characteristics, dynamic imaging changes, treatment and outcome of severe acute respiratory syndrome in Shanghai area

Survivors of SARS-CoV-2 Infection Show Neuropsychiatric Sequelae Measured by Surveys, Neurocognitive Testing, and Magnetic Resonance Imaging: Preliminary Results